Literature DB >> 10944976

[Clinical practice guidelines of the Spanish Society of Cardiology on unstable angina/infarction without ST elevation].

L López Bescós1, A Fernández-Ortiz, H Bueno Zamora, I Coma Canella, R M Lidón Corbi, A Cequier Fillat, J Tuñón Fernández, R Masiá Martorell, J Marrugat de la Iglesia, M Palencia Pérez, A Loma-Osorio, J Bayón Fernández, F Arós Borau.   

Abstract

This paper up-dates the Clinical Guidelines for Unstable Angina/Non Q wave Myocardial Infarction of the Spanish Society of Cardiology. Due to the increased efficacy of adequate management in the early phases, it has been considered necessary to include recommendations for the pre Hospital and Emergency department phase. Prehospital management. Patients with thoracic pain compatible with myocardial ischemia should be transferred to Hospital as quickly as possible and an ECG tracing performed. Initial management includes rest, sublingual nitroglycerin and aspirin. In the Emergency department. Immediate clinical attention and accessibility to a defibrillator should be available. If ECG tracing discloses ST elevation reperfusion strategy is to be implemented immediately. If no ST elevation is present, the probability of myocardial ischemia and risk factor evaluation is essential for adequate management. A simplified risk stratification classification is presented, that also determines the most adequate site for admission: Coronary Care Unit if high risk factors are present, Cardiology ward for the intermediate risk patient and ambulatory treatment if low risk. Management in Coronary Care Unit. Includes routine ECG monitoring and analgesia. Antithrombotic and anti ischemic treatment include new indication for GP IIb-IIIa and Low molecular weight heparins. Coronary arteriography and revascularisation are recommended, if refractory or recurrent angina, left ventricles dysfunction or other complications are present. Management in the ward is based on adequate chronic medical treatment, risk stratification, and secondary prevention strategy. Coronary arteriography before discharge must be considered in the light of the result of non-invasive tests.

Entities:  

Mesh:

Year:  2000        PMID: 10944976

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

1.  Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome.

Authors:  Max Brosa; Carlos Rubio-Terrés; Ibrahim Farr; Vijay Nadipelli; Jenaro Froufe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry.

Authors:  M Heras; H Bueno; A Bardají; A Fernández-Ortiz; H Martí; J Marrugat
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.